NCT06008639

Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Danyang Huichuang Medical Equipment Co., Ltd. · Industry
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

To explore the efficacy and safety of near infrared light therapy for Alzheimer's disease. Each subject will be numbered and their medical records will be established. The subjects will be randomly assigned to the treatment group or the control group for 30 minutes/day (5-6 days a week) for 4 months while the treatment group is active settings and the control group is sham settings.Follow-up visits will be conducted at 2 months, 4 months and 2 months after treatment. At each follow-up, scale assessment, blood, MRI, and EEG were observed

Conditions

• Mild to Moderate Alzheimer's Disease

Interventions

Type	Name	Description
DEVICE	treatment group-Device: NirsCure - Active NirsCure - Active settings	Treatment was performed once a day,5-6 times a week for 16 weeks.
DEVICE	placebo group-Device: NirsCure - Sham NirsCure - Sham settings	Treatment was performed once a day,5-6 times a week for 16 weeks.

Timeline

• Start date: 2023-03-01
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2023-08-23
• Last updated: 2023-09-06

Locations

2 sites across 1 country: China